
|Articles|September 17, 2019
WCG KMR Group Invites Biopharma Companies to Enroll in Cost Study
Advertisement
The WIRB-Copernicus Group’s Clinical Services Division has announces that enrollment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now open. In its fourth year, the study will produce benchmarks on trial cost and trial cost efficiency, enabling participants to realize cost savings.
For more information on the study and how to participate, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement